ВАЖНО! Правила приравнивания журналов, входящих в международные базы данных к журналам перечня ВАК.
Ответ на официальный запрос в ВАК журнала Кардиология.

Preview

Kardiologiia

Advanced search

Renal hemodynamics in patients with resistant hypertension and type 2 diabetes mellitus

https://doi.org/10.18087/cardio.2023.8.n2468

Abstract

Aim    To study renal hemodynamics in patients with resistant arterial hypertension (RAH) in combination with type 2 diabetes mellitus (DM2) and to identify factors involved in the increase in intrarenal vascular resistance.
Material and methods    This study included 59 patients (25 men) with RAH in combination with DM2. Mean age of patients was 60.3±7.9 years; 24-h blood pressure (24-BP) (systolic, diastolic, SBP/DBP) was 158.0±16.3 / 82.5±12.7 mm Hg during the treatment with 4.3 [4.0;5.0] antihypertensive drugs; glycated hemoglobin (HbA1c) was 7.5±1.5 %; estimated glomerular filtration rate (eGFR) was 73.1±21.8 ml/min / 1.73 m2 (CKD-EPI equation). Measurement of office BP, 24-h BP monitoring, renal artery (RA) Doppler, routine lab tests including determination of GFR (CKD-EPI), 24-h urine albumin excretion, and ELISA measurement of blood lipocalin-2, cystatin C, high-sensitive C-reactive protein (hsCRP), and asymmetric dimethylarginine (ADMA) were performed for all patients.
Results    Incidence of increased RA resistive index (RI) was 39% despite the high rate of vasodilator treatment (93% for renin-angiotensin-aldosterone system inhibitors, 78% for calcium antagonists). According to a correlation and regression analysis, RA RI values were correlated with the kidney function (r=-0.46, p<0.001 for eGFR, r=0.56; p=0.006 for lipocalin-2), age (r=0.54, p<0.001), increases in concentrations of hsCRP (r=0.35, p<0.001) and ADMA (r=0.39, p=0.028), the increase in vascular stiffness (r=0.59, p<0.001 for pulse BP (PBP) as well as DM2 duration, and HbA1c (r=0.33, p<0.001 for both). The independent association of RA RI with the age, PBP, and duration of DM2 was confirmed by the results of multivariate regression analysis. According to the ROC analysis, the threshold level of RA RI corresponding to a decrease in GFR <60 ml / min / 1.73 m2 was ≥0.693 conv. units.
Conclusion    In more than one third of patients with RAH in combination with DM2, increased renal vascular resistance was documented, which was closely associated with impaired kidney function, age, DM2 duration and severity, and markers of low-grade inflammation, endothelial dysfunction, and vascular stiffness. The value of RA RI ≥0.693 conv. units was a threshold for the development of chronic kidney disease (CKD).

 

About the Authors

M. A. Manukyan
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

MD, Junior Research Scientist, Department of Hypertension

Tomsk, Russia

 



A. Yu. Falkovskaya
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

Head of Department of Hypertension

Tomsk, Russia

 



I. V. Zyubanova
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

MD, PhD, Research Scientist, Department of Hypertension

Tomsk, Russia



E. I. Solonskaya
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

MD, PhD, Junior Research Scientist, Department of Hypertension

Tomsk, Russia



V. A. Lichikaki
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

MD, PhD, Research Scientist, Department of Hypertension

Tomsk, Russia

 



T. R. Ryabova
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

MD, PhD, Senior Research Scientist,
Department of Functional Diagnostics and Ultrasound

Tomsk, Russia



A. A. Vtorushina
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

Research Lab Assistant, Department of  Hypertension

Tomsk, Russia

 



S. A. Khunkhinova
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

Research Lab Assistant, Department of Hypertension, 

Tomsk, Russia



I. A. Skomkina
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

Research Lab Assistant, Department of Hypertension

Tomsk, Russia

 



A. A. Yevtukh
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

Assistant Doctor, Department of Hypertension

Tomsk, Russia

 



A. M. Gusakova
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

Cand. Sci. (Pharm.), Research Scientist, Department of Functional and Laboratory Diagnostics

Tomsk, Russia

 



V. F. Mordovin
Research Institute of Cardiology, Tomsk National Research Center of the Russian Academy of Sciences
Russian Federation

MD, Dr. Sci. (Med.), Professor, Leading Research Scientist of the Department of Hypertension

Tomsk, Russia

 



References

1. Demidova T.Yu., Kislyak O.A. Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease. Rational Pharmacotherapy in Cardiology. 2021;17(2):323–31. DOI: 10.20996/1819-6446-2021-04-06

2. Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH et al. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney International. 2021;99(3):S1–87. DOI: 10.1016/j.kint.2020.11.003

3. Heine GH, Reichart B, Ulrich C, Kohler H, Girndt M. Do ultrasound renal resistance indices reflect systemic rather than renal vascular damage in chronic kidney disease? Nephrology Dialysis Transplantation. 2006;22(1):163–70. DOI: 10.1093/ndt/gfl484

4. Delsart P, Vambergue A, Ninni S, Machuron F, Lelievre B, Ledieu G et al. Prognostic significance of the renal resistive index in the primary prevention of type II diabetes. The Journal of Clinical Hypertension. 2020;22(2):223–30. DOI: 10.1111/jch.13819

5. Doi Y, Iwashima Y, Yoshihara F, Kamide K, Hayashi S, Kubota Y et al. Renal Resistive Index and Cardiovascular and Renal Outcomes in Essential Hypertension. Hypertension. 2012;60(3):770–7. DOI: 10.1161/HYPERTENSIONAHA.112.196717

6. Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV et al. Renal Resistive Index and Mortality in Chronic Kidney Disease. Hypertension. 2015;66(2):382–8. DOI: 10.1161/HYPERTENSIONAHA.115.05536

7. Afsar B, Elsurer R. Increased renal resistive index in type 2 diabetes: Clinical relevance, mechanisms and future directions. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;11(4):291–6. DOI: 10.1016/j.dsx.2016.08.019

8. Hamano K, Nitta A, Ohtake T, Kobayashi S. Associations of Renal Vascular Resistance With Albuminuria and Other Macroangiopathy in Type 2 Diabetic Patients. Diabetes Care. 2008;31(9):1853–7. DOI: 10.2337/dc08-0168

9. Tedesco MA, Natale F, Mocerino R, Tassinario G, Calabrò R. Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients. Journal of Human Hypertension. 2007;21(4):291–6. DOI: 10.1038/sj.jhh.1002145

10. Adar A, Onalan O, Keles H, Cakan F, Kokturk U. Relationship between Aortic Arch Calcification, Detected by Chest X-Ray, and Renal Resistive Index in Patients with Hypertension. Medical Principles and Practice. 2019;28(2):133–40. DOI: 10.1159/000495786

11. Geraci G, Mulè G, Geraci C, Mogavero M, D’Ignoto F, Morreale M et al. Association of renal resistive index with aortic pulse wave velocity in hypertensive patients. European Journal of Preventive Cardiology. 2015;22(4):415–22. DOI: 10.1177/2047487314524683

12. Geraci G, Mulè G, Costanza G, Mogavero M, Geraci C, Cottone S. Relationship Between Carotid Atherosclerosis and Pulse Pressure with Renal Hemodynamics in Hypertensive Patients. American Journal of Hypertension. 2016;29(4):519–27. DOI: 10.1093/ajh/hpv130

13. Pontremoli R, Viazzi F, Martinoli C, Ravera M, Nicolella C, Berruti V et al. Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. Nephrology Dialysis Transplantation. 1999;14(2):360–5. DOI: 10.1093/ndt/14.2.360

14. Raff U, Schmidt BM, Schwab J, Schwarz TK, Achenbach S, Bär I et al. Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension. Journal of Hypertension. 2010;28(3):608–14. DOI: 10.1097/HJH.0b013e32833487b8

15. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension. 2013;31(7):1281–357. DOI: 10.1097/01.hjh.0000431740.32696.cc

16. Boddi M. Renal Ultrasound (and Doppler Sonography) in Hypertension: An Update. Advances in Experimental Medicine and Biology. 2017;956:191–208. DOI: 10.1007/5584_2016_170

17. Prejbisz A, Warchoł-Celińska E, Florczak E, Dobrowolski P, Klisiewicz A, Szwench-Pietrasz E et al. Renal resistive index in patients with true resistant hypertension: results from the RESIST-POL study. Kardiologia Polska. 2016;74(2):142–50. DOI: 10.5603/KP.a2015.0114

18. Nosadini R, Velussi M, Brocco E, Abaterusso C, Carraro A, Piarulli F et al. Increased renal arterial resistance predicts the course of renal function in type 2 diabetes with microalbuminuria. Diabetes. 2006;55(1):234–9. PMID: 16380498

19. Hashimoto J, Ito S. Central Pulse Pressure and Aortic Stiffness Determine Renal Hemodynamics: Pathophysiological Implication for Microalbuminuria in Hypertension. Hypertension. 2011;58(5):839–46. DOI: 10.1161/HYPERTENSIONAHA.111.177469

20. Kuznetsova T, Herbots L, Lopez B, Jin Y, Richart T, Thijs L et al. Prevalence of Left Ventricular Diastolic Dysfunction in a General Population. Circulation: Heart Failure. 2009;2(2):105–12. DOI: 10.1161/CIRCHEARTFAILURE.108.822627

21. Kawai T, Kamide K, Onishi M, Yamamoto-Hanasaki H, Baba Y, Hongyo K et al. Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis. Nephrology Dialysis Transplantation. 2011;26(10):3256–62. DOI: 10.1093/ndt/gfr054

22. Ponte B, Pruijm M, Ackermann D, Vuistiner P, Eisenberger U, Guessous I et al. Reference Values and Factors Associated With Renal Resistive Index in a Family-Based Population Study. Hypertension. 2014;63(1):136– 42. DOI: 10.1161/HYPERTENSIONAHA.113.02321

23. Calabia J, Torguet P, Garcia I, Martin N, Mate G, Marin A et al. The Relationship Between Renal Resistive Index, Arterial Stiffness, and Atherosclerotic Burden: The Link Between Macrocirculation and Microcirculation. The Journal of Clinical Hypertension. 2014;16(3):186–91. DOI: 10.1111/jch.12248

24. Alterini B, Mori F, Terzani E, Raineri M, Zuppiroli A, De Saint Pierre G et al. Renal resistive index and left ventricular hypertrophy in essential hypertension: a close link. Annali Italiani Di Medicina Interna. 1996;11(2):107–13. PMID: 8974435

25. Sugiura T, Wada A. Resistive index predicts renal prognosis in chronic kidney disease. Nephrology Dialysis Transplantation. 2009;24(9):2780–5. DOI: 10.1093/ndt/gfp121

26. Mostbeck GH, Gössinger HD, Mallek R, Siostrzonek P, Schneider B, Tscholakoff D. Effect of heart rate on Doppler measurements of resistive index in renal arteries. Radiology. 1990;175(2):511–3. DOI: 10.1148/radiology.175.2.2183288

27. Berni A, Ciani E, Bernetti M, Cecioni I, Berardino S, Poggesi L et al. Renal resistive index and low-grade inflammation in patients with essential hypertension. Journal of Human Hypertension. 2012;26(12):723–30. DOI: 10.1038/jhh.2011.93

28. Lai S, Ciccariello M, Dimko M, Galani A, Lucci S, Cianci R et al. Cardio-Renal Syndrome Type 4: The Correlation Between Cardiorenal Ultrasound Parameters. Kidney and Blood Pressure Research. 2016;41(5):654–62. DOI: 10.1159/000447934

29. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases. 2009;54(6):1012–24. DOI: 10.1053/j.ajkd.2009.07.020

30. Koshel’skaya O.A., Zhuravleva O.A. Markers of chronic kidney disease and disorders of renal hemodynamics in patients with medically-controlled arterial hypertension and high and very high cardiovascular risk. Russian Journal of Cardiology. 2018;23(10):112–8. DOI: 10.15829/1560-4071-2018-10-112-118

31. Halimi J-M. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. Diabetes & Metabolism. 2012;38(4):291–7. DOI: 10.1016/j.diabet.2012.04.001

32. Kuznetsova T, Cauwenberghs N, Knez J, Thijs L, Liu Y-P, Gu Y-M et al. Doppler Indexes of Left Ventricular Systolic and Diastolic Flow and Central Pulse Pressure in Relation to Renal Resistive Index. American Journal of Hypertension. 2015;28(4):535–45. DOI: 10.1093/ajh/hpu185


Review

For citations:


Manukyan M.A., Falkovskaya A.Yu., Zyubanova I.V., Solonskaya E.I., Lichikaki V.A., Ryabova T.R., Vtorushina A.A., Khunkhinova S.A., Skomkina I.A., Yevtukh A.A., Gusakova A.M., Mordovin V.F. Renal hemodynamics in patients with resistant hypertension and type 2 diabetes mellitus. Kardiologiia. 2023;63(8):42-49. https://doi.org/10.18087/cardio.2023.8.n2468

Views: 1060


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0022-9040 (Print)
ISSN 2412-5660 (Online)